We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -8.00 | -0.56% | 1,427.00 | 1,429.00 | 1,437.00 | 1,456.00 | 1,420.00 | 1,420.00 | 172,925 | 16:35:05 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 968.92 | 1.94B |
From May 2019 to May 2024
TIDMINDV
RNS Number : 0498Q
Indivior PLC
16 October 2019
Indivior PLC - Directorate Change
Slough UK and Richmond VA October 16, 2019 - The Board of Indivior PLC is pleased to announce the appointment of Graham Hetherington as an independent Non-Executive Director of the Company with effect from November 1, 2019. Graham will also be appointed as a member of the Audit Committee with effect from the same date.
Howard Pien, Chair, commented:
'As announced in July 2019, we have undertaken an external search to identify an additional independent Non-Executive Director. We are delighted to announce that Graham Hetherington has agreed to join the Board. Graham brings with him a strong track record of industry and financial experience having served as the Chief Financial Officer of two FTSE 100 companies. Until recently, Graham was Senior Independent Director and Chair of the Audit Committee of BTG plc, a global healthcare company.'
Graham was Chair of the Audit Committee of BTG plc from 2016 and Senior Independent Director from 2017 until its acquisition by Boston Scientific Corporation in August 2019. He was previously Chief Financial Officer of Shire PLC, a global pharmaceutical company with a market capitalisation of over GBP33bn, from 2008 until 2014, Chief Financial Officer of Bacardi and Company between 2007-08 and Chief Financial Officer of Allied Domecq plc from 1999 to 2005. He is a Fellow of the Chartered Institute of Management Accountants.
There is no further information to disclose in relation to Graham Hetherington's appointment in accordance with LR 9.6.13.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOAMFBRTMBABMTL
(END) Dow Jones Newswires
October 16, 2019 04:30 ET (08:30 GMT)
1 Year Indivior Chart |
1 Month Indivior Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
